Systemic vasculitis

Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study
Matthew J Koster, Cynthia S Crowson, Rachel E Giblon, Jane M Jaquith, Ali Duarte-García, Eric L Matteson, Cornelia M Weyand, Kenneth J Warrington

Annals of the Rheumatic Diseases Jun 2022, 81 (6) 861-867; DOI: 10.1136/annrheumdis-2021-221961
Response to: ‘Diagnostic accuracy of novel ultrasonographic halo score for giant cell arteritis: methodological issues’ by Ghajari and Sabour
Kornelis SM van der Geest, Frances Borg, Abdul Kayani, Davy Paap, Prisca Gondo, Wolfgang Schmidt, Raashid Ahmed Luqmani, Bhaskar Dasgupta

Annals of the Rheumatic Diseases Jun 2022, 81 (6) e106; DOI: 10.1136/annrheumdis-2020-218144
Error in the dosage of Methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Dennis Scheicht

Annals of the Rheumatic Diseases Jun 2022, 81 (6) e89; DOI: 10.1136/annrheumdis-2020-217041
Response to: ‘Error in the dosage of methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis’ by Scheicht
Chetan B Mukhtyar, Bernhard Hellmich

Annals of the Rheumatic Diseases Jun 2022, 81 (6) e90; DOI: 10.1136/annrheumdis-2020-217063
Comment on ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis’ by Kuwabara et al
Valeria Rios Rodriguez, Judith Rademacher, Mikhail Protopopov, Murat Torgutalp, Hildrun Haibel, Janis Lucas Vahldiek, Ann-Christin von Brünneck, Safwan Omran, Denis Poddubnyy, Fabian Proft

Annals of the Rheumatic Diseases Jun 2022, 81 (6) e93; DOI: 10.1136/annrheumdis-2020-217894
Response to: ‘Comment on ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis’ by Kuwabara et al’ by Rios Rodriguez et al
Shun Tanimura, Hiroyuki Nakamura, Tetsuya Horita

Annals of the Rheumatic Diseases Jun 2022, 81 (6) e94; DOI: 10.1136/annrheumdis-2020-218055
Bowman’s capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications
Vincenzo L'Imperio, Gisella Vischini, Fabio Pagni, Pietro Manuel Ferraro

Annals of the Rheumatic Diseases Jun 2022, 81 (6) e95; DOI: 10.1136/annrheumdis-2020-217979
Response to: ‘Bowman's capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications’ by L'Imperio et al
Dilek Solmaz, Servet Akar

Annals of the Rheumatic Diseases Jun 2022, 81 (6) e96; DOI: 10.1136/annrheumdis-2020-218035
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
George C Drosos, Daisy Vedder, Eline Houben, Laura Boekel, Fabiola Atzeni, Sara Badreh, Dimitrios T Boumpas, Nina Brodin, Ian N Bruce, Miguel Ángel González-Gay, Søren Jacobsen, György Kerekes, Francesca Marchiori, Chetan Mukhtyar, Manuel Ramos-Casals, Naveed Sattar, Karen Schreiber, Savino Sciascia, Elisabet Svenungsson, Zoltan Szekanecz, Anne-Kathrin Tausche, Alan Tyndall, Vokko van Halm, Alexandre Voskuyl, Gary J Macfarlane, Michael M Ward, Michael T Nurmohamed, Maria G Tektonidou

Annals of the Rheumatic Diseases Jun 2022, 81 (6) 768-779; DOI: 10.1136/annrheumdis-2021-221733
CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritis
Anthony Rousselle, Janis Sonnemann, Kerstin Amann, Alexander Mildner, Dörte Lodka, Lovis Kling, Markus Bieringer, Udo Schneider, Achim Leutz, Philipp Enghard, Ralph Kettritz, Adrian Schreiber

Annals of the Rheumatic Diseases Apr 2022, annrheumdis-2021-221984; DOI: 10.1136/annrheumdis-2021-221984

Main menu

Systemic vasculitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Systemic vasculitis

Pages